Stroke is the number one cause of adult disability in the United States. The most common type of stroke is ischemic (non-bleeding), which occurs when there is sudden loss of blood flow to an area of ...

Boehringer Ingelheim and the Lower Franconian biotech company EMFRET Analytics have signed a cooperation and license ...

Recombinant human prourokinase is noninferior to alteplase for acute ischemic stroke outcomes and is associated with decreased rates of symptomatic intracranial hemorrhage and major bleeding, a new ...

TNKase is administered as a single intravenous bolus over 5 seconds. The Food and Drug Administration (FDA) has approved TNKase ® (tenecteplase) for the treatment of acute ischemic stroke (AIS) in ...

For acute ischemic stroke within 48 hours of onset, the novel sublingual combination of edaravone (Radicava) with dexborneol appeared to dramatically improve functional outcomes in the phase III TASTE ...

Despite major advances in acute stroke care, rehabilitation in the first hours to days after stroke remains inconsistently delivered, with ongoing ...

Early identification of stroke type could be key to harnessing the benefits of very early in-ambulance blood pressure lowering treatment in patients with suspected acute stroke, according to new ...

Key points A 68-year-old woman presented to the emergency department of a rural hospital in southern Alberta 1 hour after ...

Please provide your email address to receive an email when new articles are posted on . Researchers conducted a literature review for informed consent with acute ischemic stroke. Decisions should ...